647 related articles for article (PubMed ID: 28436197)
21. Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.
Allaix ME; Arezzo A; Morino M
Surg Endosc; 2016 Nov; 30(11):4841-4852. PubMed ID: 26902614
[TBL] [Abstract][Full Text] [Related]
22. Transanal Endoscopic Microsurgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Issa N; Murninkas A; Schmilovitz-Weiss H; Agbarya A; Powsner E
J Laparoendosc Adv Surg Tech A; 2015 Aug; 25(8):617-24. PubMed ID: 26258267
[TBL] [Abstract][Full Text] [Related]
23. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
[TBL] [Abstract][Full Text] [Related]
24. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
Wang Y; Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
[TBL] [Abstract][Full Text] [Related]
25. Extending the role of Transanal Endoscopic Microsurgery (TEM) in rectal cancer.
Hompes R; Cunningham C
Colorectal Dis; 2011 Nov; 13 Suppl 7():32-6. PubMed ID: 22098515
[TBL] [Abstract][Full Text] [Related]
26. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
27. MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy.
Lambregts DM; Lahaye MJ; Heijnen LA; Martens MH; Maas M; Beets GL; Beets-Tan RG
Eur Radiol; 2016 Jul; 26(7):2118-25. PubMed ID: 26518582
[TBL] [Abstract][Full Text] [Related]
28. Management and outcome of local recurrence following transanal endoscopic microsurgery for rectal cancer.
Stipa F; Giaccaglia V; Burza A
Dis Colon Rectum; 2012 Mar; 55(3):262-9. PubMed ID: 22469792
[TBL] [Abstract][Full Text] [Related]
29. National Early Rectal Cancer Treatment Revisited.
Stornes T; Wibe A; Nesbakken A; Myklebust TÅ; Endreseth BH
Dis Colon Rectum; 2016 Jul; 59(7):623-9. PubMed ID: 27270514
[TBL] [Abstract][Full Text] [Related]
30. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
[TBL] [Abstract][Full Text] [Related]
31. The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review.
Zinicola R; Nascimbeni R; Cirocchi R; Gagliardi G; Cracco N; Giuffrida M; Pedrazzi G; Binda GA
Tech Coloproctol; 2021 Sep; 25(9):997-1010. PubMed ID: 34173121
[TBL] [Abstract][Full Text] [Related]
32. Local excision after (near) complete response of rectal cancer to neoadjuvant radiation: does it add value?
Jones HJS; Al-Najami I; Baatrup G; Cunningham C
Int J Colorectal Dis; 2021 May; 36(5):1017-1022. PubMed ID: 33409564
[TBL] [Abstract][Full Text] [Related]
33. Complete response after neoadjuvant therapy in rectal cancer: to operate or not to operate?
Dedemadi G; Wexner SD
Dig Dis; 2012; 30 Suppl 2():109-17. PubMed ID: 23207942
[TBL] [Abstract][Full Text] [Related]
34. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
35. Oncological Outcomes of Transanal Endoscopic Microsurgery Plus Adjuvant Chemoradiotherapy for Patients with High-Risk T1 and T2 Rectal Cancer.
Xu K; Liu Y; Yu P; Shang W; Zhang Y; Jiao M; Cui Z; Xia L; Chen J
J Laparoendosc Adv Surg Tech A; 2021 Sep; 31(9):1006-1013. PubMed ID: 33026943
[No Abstract] [Full Text] [Related]
36. Fragmented pattern of tumor regression and lateral intramural spread may influence margin appropriateness after TEM for rectal cancer following neoadjuvant CRT.
Perez RO; Habr-Gama A; Smith FM; Kosinski L; São Julião GP; Grzona E; Rawet V; Vianna MR; Proscurshim I; Lynn PB; Gama-Rodrigues J
J Surg Oncol; 2014 Jun; 109(8):853-8. PubMed ID: 24862927
[TBL] [Abstract][Full Text] [Related]
37. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
Lin Y; Lin H; Xu Z; Zhou S; Chi P
J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
[No Abstract] [Full Text] [Related]
38. Features of Late Recurrence Following Transanal Local Excision for Early Rectal Cancer.
Oh BY; Yun HR; Kim SH; Yun SH; Kim HC; Lee WY; Chun HK; Cho YB
Dis Colon Rectum; 2015 Nov; 58(11):1041-7. PubMed ID: 26445176
[TBL] [Abstract][Full Text] [Related]
39. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E
Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401
[TBL] [Abstract][Full Text] [Related]
40. Outcomes in locally advanced rectal cancer with highly selective preoperative chemoradiotherapy.
Williamson JS; Jones HG; Davies M; Evans MD; Hatcher O; Beynon J; Harris DA;
Br J Surg; 2014 Sep; 101(10):1290-8. PubMed ID: 24924947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
